Long noncoding RNA variations in cardiometabolic diseases

Journal of Human Genetics

Volumn 62, Issue 1, 2017, Pages 97-104

  Dechamethakun, Sariya ^a   Muramatsu, Masaaki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANRIL PROTEIN; BINDING PROTEIN; DLK1 POTEIN; GROWTH ARREST SPECIFIC PROTEIN 5; HISTONE; HISTONE H19; HL LNC25 PROTEIN; KCNQ1OT1 PROTEIN; LONG INTERGENIC NONCODING RNA PREDICTING CARDIAC REMODELING; LONG UNTRANSLATED RNA; MATERNAL EXPRESSED GENE 3 PROTEIN; METASTASIS ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1 PROTEIN; MYOCARDIAL INFARCTION ASSOCIATED TRANSCRIPT PROTEIN; NONHSAG044354 PROTEIN; OXIDOREDUCTASE; POTASSIUM CHANNEL KCNQ1; RNA; TRANSCRIPTION FACTOR; TRANSCRIPTOME; TUMOR MARKER; UNCLASSIFIED DRUG; UNTRANSLATED RNA; VON WILLEBRAND FACTOR;

ALTERNATIVE RNA SPLICING; ATHEROSCLEROSIS; CARDIOMETABOLIC DISEASE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; EXON; GENE EXPRESSION; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIATION; HEART DISEASE; HEART INFARCTION; HIGH THROUGHPUT SEQUENCING; HUMAN; METABOLIC DISORDER; OBESITY; PHENOTYPE; PLASMA; PROTEIN RNA BINDING; REVIEW; SERUM; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS; URINE; CARDIOVASCULAR DISEASE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HUMAN GENOME; PROCEDURES; SINGLE NUCLEOTIDE POLYMORPHISM;

CARDIOVASCULAR DISEASES; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; OBESITY; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, LONG NONCODING;

EID: 85008613407     PISSN: 14345161     EISSN: 1435232X     Source Type: Journal    
DOI: 10.1038/jhg.2016.70     Document Type: Review

References (150)

1. Matsuzawa, Y., Funahashi, T. & Nakamura, T. The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. J. Atheroscler. Thromb. 18, 629-639 (2011).
2. Grundy, S. M. Metabolic syndrome pandemic. Arterioscler. Thromb. Vasc. Biol. 28, 629-636 (2008).
3. Castro, J. P., El-Atat, F. A., McFarlane, S. I., Aneja, A. & Sowers, J. R. Cardiometabolic syndrome: pathophysiology and treatment. Curr. Hypesrtens. Rep. 53, 93-401 (2003).
4. Braunwald, E. Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N. Engl. J. Med. 337, 1360-1369 (1997).
5. Turgeon, P. J., Sukumar, A. N. & Marsden, P. A. Epigenetics of cardiovascular disease - a new 'beat' in coronary artery disease. Med. Epigenet. 2, 37-52 (2014).
6. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74 (2012).
7. Paul, D. S., Soranzo, N. & Beck, S. Functional interpretation of non-coding sequence variation: concepts and challenges. Bioessays36, 191-199 (2014).
8. Siggens, L. & Ekwall, K. Epigenetics, chromatin and genome organization: recent advances from the ENCODE project. J. Intern. Med. 276, 201-214 (2014).
9. Uchida, S. & Dimmeler, S. Long noncoding RNAs in cardiovascular diseases. Circ. Res. 116, 737-750 (2015).
10. Aryal, B., Rotllan, N. & Fernández-Hernando, C. Noncoding RNAs and atherosclerosis. Curr. Atheroscler. Rep. 16, 407 (2014).
11. Fu, X. D. Non-coding RNA: a new frontier in regulatory biology. Natl. Sci. Rev. 1, 190-204 (2014).
12. Esteller, M. Non-coding RNAs in human disease. Nat. Rev. Genet. 12, 861-874 (2011).
13. Elia, L. & Condorelli, G. RNA (Epi)genetics in cardiovascular diseases. J. Mol. Cell. Cardiol. 89, 11-16 (2015).
14. Wang, K. C. & Chang, H. Y. Molecular mechanisms of long noncoding RNAs. Mol. Cell. 43, 904-914 (2011).
15. Quinn, J. J. & Chang, H. Y. Unique features of long non-coding RNA biogenesis and function. Nat. Rev. Genet. 17, 47-62 (2015).
16. Kung, J. T., Colognori, D. & Lee, J. T. Long noncoding RNAs: past, present, and future. Genetics 193, 651-669 (2013).
17. Hrdlickova, B., de Almeida, R. C., Borek, Z. & Withoff, S. Genetic variation in the non-coding genome: involvement of micro-RNAs and long non-coding RNAs in disease. Biochim. Biophys. Acta. 1842, 1910-1922 (2014).
18. Cheetham, S. W., Gruhl, F., Mattick, J. S. & Dinger, M. E. Long noncoding RNAs and the genetics of cancer. Br. J. Cancer 108, 2419-2425 (2013).
19. St Laurent, G., Wahlestedt, C. & Kapranov, P. The landscape of long noncoding RNA classification. Trends. Genet. 31, 239-251 (2015).
20. Harrow, J., Frankish, A., Gonzalez, J. M., Tapanari, E., Diekhans, M., Kokocinski, F. et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res. 22, 1760-1774 (2012).
21. Kumar, V., Westra, H. J., Karjalainen, J., Zhernakova, D. V., Esko, T., Hrdlickova, B. et al. Human disease-associated genetic variation impacts large intergenic non-coding RNA expression. PLoS Genet. 9, e1003201 (2013).
22. Trinklein, N. D., Aldred, S. F., Hartman, S. J., Schroeder, D. I., Otillar, R. P. & Myers, R. M. An abundance of bidirectional promoters in the human genome. Genome Res. 14, 62-66 (2004).
23. Pandey, R. R., Mondal, T., Mohammad, F., Enroth, S., Redrup, L., Komorowski, J. et al. Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol. Cell. 32, 232-246 (2008).
24. Travers, M. E., Mackay, D. J., Dekker, N. M., Morris, A. P., Lindgren, C. M., Berry, A. et al. Insights into the molecular mechanism for type 2 diabetes susceptibility at the KCNQ1 locus from temporal changes in imprinting status in human islets. Diabetes 62, 987-992 (2013).
25. Rinn, J. L. & Chang, H. Y. Genome regulation by long noncoding RNAs. Annu. Rev. Biochem. 81, 145-166 (2012).
26. Kino, T., Hurt, D. E., Ichijo, T., Nader, N. & Chrousos, G. P. Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci. Signal 3, ra8 (2010).
27. Rizki, G. & Boyer, L. A. Lncing epigenetic control of transcription to cardiovascular development and disease. Circ. Res. 117, 192-206 (2015).
28. Sun, B. K., Deaton, A. M. & Lee, J. T. A transient heterochromatic state in Xist preempts X inactivation choice without RNA stabilization. Mol. Cell. 21, 617-628 (2006).
29. Spitale, R. C., Tsai, M. C. & Chang, H. Y. RNA templating the epigenome: long noncoding RNAs as molecular scaffolds. Epigenetics 6, 539-543 (2011).
30. Yap, K. L., Li, S., Muñoz-Cabello, A. M., Raguz, S., Zeng, L., Mujtaba, S. et al. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol. Cell 38, 662-674 (2010).
31. Kotake, Y., Nakagawa, T., Kitagawa, K., Suzuki, S., Liu, N., Kitagawa, M. et al. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15 (INK4B) tumor suppressor gene. Oncogene 30, 1956-1962 (2011).
32. Aguilo, F., Zhou, M. M. & Walsh, M. J. Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression. Cancer Res. 71, 5365-5369 (2011).
33. Kumarswamy, R., Bauters, C., Volkmann, I., Maury, F., Fetisch, J., Holzmann, A. et al. Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure. Circ. Res. 114, 1569-1575 (2014).
34. Carter, G., Miladinovic, B., Patel, A. A., Deland, L., Mastorides, S. & Patel, N. A. Circulating long noncoding RNA GAS5 levels are correlated to prevalence of type 2 diabetes mellitus. BBA Clin. 4, 102-107 (2015).
35. Tong, Y. K. & Lo, Y. M. Diagnostic developments involving cell-free (circulating) nucleic acids. Clin. Chim. Acta. 363, 187-196 (2006).
36. Reis, E. M. & Verjovski-Almeida, S. Perspectives of long non-coding RNAs in cancer diagnostics. Front. Genet. 3, 32 (2012).
37. Pickard, M. R., Mourtada-Maarabouni, M. & Williams, G. T. Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines. Biochim. Biophys. Acta. 1832, 1613-1623 (2013).
38. Pickard, M. R. & Williams, G. T. Regulation of apoptosis by long non-coding RNA GAS5 in breast cancer cells: implications for chemotherapy. Breast Cancer Res. Treat. 145, 359-370 (2014).
39. Ji, P., Diederichs, S., Wang, W., Böing, S., Metzger, R., Schneider, P. M. et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22, 8031-8041 (2003).
40. Kameswaran, V. & Kaestner, K. H. The missing lnc(RNA) between the pancreatic β-cell and diabetes. Front. Genet. 5, 200 (2014).
41. Puthanveetil, P., Chen, S., Feng, B., Gautam, A. & Chakrabarti, S. Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells. J. Cell. Mol. Med. 19, 1418-1425 (2015).
42. Liu, J. Y., Yao, J., Li, X. M., Song, Y. C., Wang, X. Q., Li, Y. J. et al. Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus. Cell Death Dis. 5, e1506 (2014).
43. Morán, I., Akerman, I., van de Bunt, M., Xie, R., Benazra, M., Nammo, T. et al. Human β cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes. Cell. Metab. 16, 435-448 (2012).
44. Artner, I., Blanchi, B., Raum, J. C., Guo, M., Kaneko, T., Cordes, S. et al. MafB is required for islet beta cell maturation. Proc. Natl Acad. Sci. USA 104, 3853-3858 (2007).
45. Conrad, E., Dai, C., Spaeth, J., Guo, M., Cyphert, H. A., Scoville, D. et al. The MAFB transcription factor impacts islet α-cell function in rodents and represents a unique signature of primate islet β-cells. Am. J. Physiol. Endocrinol. Metab. 310, E91-E102 (2016).
46. Senée, V., Chelala, C., Duchatelet, S., Feng, D., Blanc, H., Cossec, J. C. et al. Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism. Nat. Genet. 38, 682-687 (2006).
47. Nogueira, T. C., Paula, F. M., Villate, O., Colli, M. L., Moura, R. F., Cunha, D. A. et al. GLIS3, a susceptibility gene for type 1 and type 2 diabetes, modulates pancreatic beta cell apoptosis via regulation of a splice variant of the BH3-only protein Bim. PLoS Genet. 9, e1003532 (2013).
48. Pullen, T. J. & Rutter, G. A. Roles of lncRNAs in pancreatic beta cell identity and diabetes susceptibility. Front. Genet. 5, 193 (2014).
49. Liu, Y., Ferguson, J. F., Xue, C., Ballantyne, R. L., Silverman, I. M., Gosai, S. J. et al. Tissue-specific RNA-Seq in human evoked inflammation identifies blood and adipose LincRNA signatures of cardiometabolic diseases. Arterioscler. Thromb. Vasc. Biol. 34, 902-912 (2014).
50. Bhartiya, D. & Scaria, V. Genomic variations in non-coding RNAs: structure, function and regulation. Genomics 107, 59-68 (2016).
51. Shastry, B. S. SNPs: impact on gene function and phenotype. Methods Mol. Biol. 578, 3-22 (2009).
52. Hindorff, L. A., Sethupathy, P., Junkins, H. A., Ramos, E. M., Mehta, J. P., Collins, F. S. et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl Acad. Sci. USA 106, 9362-9367 (2009).
53. Pasmant, E., Sabbagh, A., Vidaud, M. & Bièche, I. ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J. 25, 444-448 (2011).
54. Gao, W., Zhu, M., Wang, H., Zhao, S., Zhao, D., Yang, Y. et al. Association of polymorphisms in long non-coding RNA H19 with coronary artery disease risk in a Chinese population. Mutat. Res. 772, 15-22 (2015).
55. Batista, P. J. & Chang, H. Y. Long noncoding RNAs: cellular address codes in development and disease. Cell 152, 1298-1307 (2013).
56. Johnson, R., Richter, N., Jauch, R., Gaughwin, P. M., Zuccato, C., Cattaneo, E. et al. Human accelerated region 1 noncoding RNA is repressed by REST in Huntington's disease. Physiol. Genomics 41, 269-274 (2010).
57. Shirasawa, S., Harada, H., Furugaki, K., Akamizu, T., Ishikawa, N., Ito, K. et al. SNPs in the promoter of a B cell-specific antisense transcript, SAS-ZFAT, determine susceptibility to autoimmune thyroid disease. Hum. Mol. Genet. 13, 2221-2231 (2004).
58. Sonkoly, E., Bata-Csorgo, Z., Pivarcsi, A., Polyanka, H., Kenderessy-Szabo, A., Molnar, G. et al. Identification and characterization of a novel, psoriasis susceptibility-related noncoding RNA gene, PRINS. J. Biol. Chem. 280, 24159-24167 (2005).
59. Zhang, X., Gejman, R., Mahta, A., Zhong, Y., Rice, K. A., Zhou, Y. et al. Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res. 70, 2350-2358 (2010).
60. Gupta, R. A., Shah, N., Wang, K. C., Kim, J., Horlings, H. M., Wong, D. J. et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071-1076 (2010).
61. Li, J., Xuan, Z. & Liu, C. Long non-coding RNAs and complex human diseases. Int. J. Mol. Sci. 14, 18790-18808 (2013).
62. Gong, J., Liu, W., Zhang, J., Miao, X. & Guo, A. Y. lncRNASNP: a database of SNPs in lncRNAs and their potential functions in human and mouse. Nucleic Acids Res. 43, D181-D186 (2015).
63. Halvorsen, M., Martin, J. S., Broadaway, S. & Laederach, A. Disease-associated mutations that alter the RNA structural ensemble. PLoS Genet. 6, e1001074 (2010).
64. Congrains, A., Kamide, K., Oguro, R., Yasuda, O., Miyata, K., Yamamoto, E. et al. Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B. Atherosclerosis 220, 449-455 (2012).
65. Ishii, N., Ozaki, K., Sato, H., Mizuno, H., Saito, S., Takahashi, A. et al. Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction. J. Hum. Genet. 51, 1087-1099 (2006).
66. Pasmant, E., Laurendeau, I., Héron, D., Vidaud, M., Vidaud, D. & Bièche, I. Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res. 67, 3963-3969 (2007).
67. Helgadottir, A., Thorleifsson, G., Manolescu, A., Gretarsdottir, S., Blondal, T., Jonasdottir, A. et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316, 1491-1493 (2007).
68. McPherson, R., Pertsemlidis, A., Kavaslar, N., Stewart, A., Roberts, R., Cox, D. R. et al. A common allele on chromosome 9 associated with coronary heart disease. Science 316, 1488-1491 (2007).
69. Dechamethakun, S., Ikeda, S., Arai, T., Sato, N., Sawabe, M. & Muramatsu, M. Associations between the CDKN2A/B, ADTRP and PDGFD polymorphisms and the development of coronary atherosclerosis in Japanese patients. J. Atheroscler. Thromb. 21, 680-690 (2014).
70. Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I., Chen, H. et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316, 1331-1336 (2007).
71. Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L. et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316, 1341-1345 (2007).
72. Helgadottir, A., Thorleifsson, G., Magnusson, K. P., Grétarsdottir, S., Steinthorsdottir, V., Manolescu, A. et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat. Genet. 40, 217-224 (2008).
73. Turnbull, C., Ahmed, S., Morrison, J., Pernet, D., Renwick, A., Maranian, M. et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat. Genet. 42, 504-507 (2010).
74. Bishop, D. T., Demenais, F., Iles, M. M., Harland, M., Taylor, J. C., Corda, E. et al. Genome-wide association study identifies three loci associated with melanoma risk. Nat. Genet. 41, 920-925 (2009).
75. Falchi, M., Bataille, V., Hayward, N. K., Duffy, D. L., Bishop, J. A., Pastinen, T. et al. Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi. Nat. Genet. 41, 915-919 (2009).
76. Jarinova, O., Stewart, A. F., Roberts, R., Wells, G., Lau, P., Naing, T. et al. Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus. Arterioscler. Thromb. Vasc. Biol. 29, 1671-1677 (2009).
77. Broadbent, H. M., Peden, J. F., Lorkowski, S., Goel, A., Ongen, H., Green, F. et al. Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum. Mol. Genet. 17, 806-814 (2008).
78. Holdt, L. M., Hoffmann, S., Sass, K., Langenberger, D., Scholz, M., Krohn, K. et al. Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks. PLoS Genet. 9, e1003588 (2013).
79. Visel, A., Zhu, Y., May, D., Afzal, V., Gong, E., Attanasio, C. et al. Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature 464, 409-412 (2010).
80. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3000 shared controls. Nature 447, 661-678 (2007).
81. Liu, Y., Sanoff, H. K., Cho, H., Burd, C. E., Torrice, C., Mohlke, K. L. et al. INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis. PLoS One 4, e5027 (2009).
82. Hannou, S. A., Wouters, K., Paumelle, R. & Staels, B. Functional genomics of the CDKN2A/B locus in cardiovascular and metabolic disease: what have we learned from GWASs? Trends Endocrinol. Metab. 26, 176-184 (2015).
83. Cunnington, M. S., Santibanez Koref, M., Mayosi, B. M., Burn, J. & Keavney, B. Chromosome 9p21 SNPs associated with multiple disease phenotypes correlate with ANRIL expression. PLoS Genet. 6, e1000899 (2010).
84. Holdt, L. M., Sass, K., Gäbel, G., Bergert, H., Thiery, J. & Teupser, D. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque. Atherosclerosis 214, 264-270 (2011).
85. Motterle, A., Pu, X., Wood, H., Xiao, Q., Gor, S., Ng, F. L. et al. Functional analyses of coronary artery disease associated variation on chromosome 9p21 in vascular smooth muscle cells. Hum. Mol. Genet. 21, 4021-4029 (2012).
86. Wan, G., Mathur, R., Hu, X., Liu, Y., Zhang, X., Peng, G. et al. Long non-coding RNA ANRIL (CDKN2B-AS) is induced by the ATM-E2F1 signaling pathway. Cell Signal 25, 1086-1095 (2013).
87. Gabory, A., Ripoche, M. A., Yoshimizu, T. & Dandolo, L. The H19 gene: regulation and function of a non-coding RNA. Cytogenet. Genome Res. 113, 188-193 (2006).
88. Gabory, A., Jammes, H. & Dandolo, L. The H19 locus: role of an imprinted non-coding RNA in growth and development. Bioessays 32, 473-480 (2010).
89. Bergman, D., Halje, M., Nordin, M. & Engström, W. Insulin-like growth factor 2 in development and disease: a mini-review. Gerontology 59, 240-249 (2013).
90. Han, D. K., Khaing, Z. Z., Pollock, R. A., Haudenschild, C. C. & Liau, G. H19, a marker of developmental transition, is reexpressed in human atherosclerotic plaques and is regulated by the insulin family of growth factors in cultured rabbit smooth muscle cells. J. Clin. Invest. 97, 1276-1285 (1996).
91. Li, L., Xie, J., Zhang, M. & Wang, S. Homocysteine harasses the imprinting expression of IGF2 and H19 by demethylation of differentially methylated region between IGF2/H19 genes. Acta. Biochim. Biophys. Sin. (Shanghai) 41, 464-471 (2009).
92. Guo, C. Y., Gu, Y., Li, L., Jia, E. Z., Li, C. J., Wang, L. S. et al. Association of SNP rs6903956 on chromosome 6p24.1 with angiographical characteristics of coronary atherosclerosis in a Chinese population. PLoS One 7, e43732 (2012).
93. Wilkin, F., Paquette, J., Ledru, E., Hamelin, C., Pollak, M. & Deal, C. L. H19 sense and antisense transgenes modify insulin-like growth factor-II mRNA levels. Eur. J. Biochem. 267, 4020-4027 (2000).
94. Nordin, M., Bergman, D., Halje, M., Engström, W. & Ward, A. Epigenetic regulation of the Igf2/H19 gene cluster. Cell Prolif. 47, 189-199 (2014).
95. Petry, C. J., Ong, K. K., Barratt, B. J., Wingate, D., Cordell, H. J., Ring, S. M. et al. Common polymorphism in H19 associated with birthweight and cord blood IGF-II levels in humans. BMC Genet. 6, 22 (2005).
96. Gatford, K. L, Heinemann, G. K., Thompson, S. D., Zhang, J. V., Buckberry, S., Owens, J. A. et al. Circulating IGF1 and IGF2 and SNP genotypes in men and pregnant and non-pregnant women. Endocr. Connect. 3, 138-149 (2014).
97. Gieger, C, Radhakrishnan, A., Cvejic, A., Tang, W., Porcu, E., Pistis, G. et al. New gene functions in megakaryopoiesis and platelet formation. Nature 480, 201-208 (2011).
98. Sadler, J. E. von Willebrand factor: two sides of a coin. J. Thromb. Haemost. 3, 1702-1709 (2005).
99. Chu, S. G., Becker, R. C, Berger, P. B., Bhatt, D. L, Eikelboom, J. W., Konkle, B. et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J. Thromb. Haemost. 8, 148-156 (2010).
100. 100Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H. et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316, 1336-1341 (2007).
101. Horikawa, Y., Miyake, K., Yasuda, K., Enya, M., Hirota, Y., Yamagata, K. et al. Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan. J. Clin. Endocrinol. Metab. 93, 3136-3141 (2008).
102. Lee, Y. H., Kang, E. S., Kim, S. H., Han, S. J., Kim, C. H., Kim, H. J. et al. Association between polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population. J. Hum. Genet. 53, 991-998 (2008).
103. Wen, J., Rönn, T., Olsson, A., Yang, Z., Lu, B., Du, Y. et al. Investigation of type 2 diabetes risk alleles support CDKN2A/B, CDKAL1, and TCF7L2 as susceptibility genes in a Han Chinese cohort. PLoS One 5, e9153 (2010).
104. Grarup, N., Rose, C. S., Andersson, E. A., Andersen, G., Nielsen, A. L, Albrechtsen, A. et al. Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects: validation and extension of genome-wide association studies. Diabetes 56, 3105-3111 (2007).
105. Omori, S., Tanaka, Y., Takahashi, A., Hirose, H., Kashiwagi, A., Kaku, K. et al. Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population. Diabetes 57, 791-795 (2008).
106. Chauhan, G., Spurgeon, C. J., Tabassum, R., Bhaskar, S., Kulkarni, S. R., Mahajan, A. et al. Impact of common variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2, and CDKAL1 on the risk of type 2 diabetes in 5164 Indians. Diabetes 59, 2068-2074 (2010).
107. Rees, S. D., Hydrie, M. Z., Shera, A. S., Kumar, S., O'Hare, J. P., Barnett, A. H. et al. Replication of 13 genome-wide association (GWA)-validated risk variants for type 2 diabetes in Pakistani populations. Diabetologia 54, 1368-1374 (2011).
108. Sherry, S. T., Ward, M. H., Kholodov, M., Baker, J., Phan, L, Smigielski, E. M. et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29, 308-311 (2001).
109. Barrett, J. C, Fry, B., Maller, J. & Daly, M. J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265 (2005).
110. Knoll, M., Lodish, H. F. & Sun, L. Long non-coding RNAs as regulators of the endocrine system. Nat. Rev. Endocrinol. 11, 151-160 (2015).
111. Cerf, M. E. Beta cell dysfunction and insulin resistance. Front. Endocrinol. (Lausanne) 4, 37 (2013).
112. Hribal, M. L., Presta, I., Procopio, T., Marini, M. A., Stancáková, A., Kuusisto, J. et al. Glucose tolerance, insulin sensitivity and insulin release in European non-diabetic carriers of a polymorphism upstream of CDKN2A and CDKN2B. Diabetologia 54, 795-802 (2011).
113. 't Hart, L. M., Simonis-Bik, A. M., Nijpels, G., van Haeften,, T. W., Schäfer, S. A., Houwing-Duistermaat, J. J. et al. Combined risk allele score of eight type 2 diabetes genes is associated with reduced first-phase glucose-stimulated insulin secretion during hyperglycemic clamps. Diabetes 59, 287-292 (2010).
114. Krishnamurthy, J., Ramsey, M. R., Ligon, K. L., Torrice, C, Koh, A., Bonner-Weir, S. et al. p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 443, 453-457 (2006).
115. Chen, H., Gu, X., Su, I. H., Bottino, R., Contreras, J. L., Tarakhovsky, A. et al. Polycomb protein Ezh2 regulates pancreatic beta-cell Ink4a/Arf expression and regeneration in diabetes mellitus. Genes Dev. 23, 975-985 (2009).
116. Dhawan, S., Tschen, S. I. & Bhushan, A. Bmi-1 regulates the Ink4a/Arf locus to control pancreatic beta-cell proliferation. Genes Dev. 23, 906-911 (2009).
117. Cannon, C. E., Titchenell, P. M., Groff, D. N., El, Ouaamari., A., Kulkarni, R. N., Birnbaum, M. J. et al. The Polycomb protein, Bmi1, regulates insulin sensitivity. Mol. Metab. 3, 794-802 (2014).
118. Bantubungi, K., Hannou, S. A., Caron-Houde, S., Vallez, E., Baron, M., Lucas, A. et al. Cdkn2a/p16Ink4a regulates fasting-induced hepatic gluconeogenesis through the PKA-CREB-PGC1a pathway. Diabetes 63, 3199-3209 (2014).
119. Fitzpatrick, G. V., Soloway, P. D. & Higgins, M. J. Regional loss of imprinting and growth deficiency in mice with a targeted deletion of KvDMR1. Nat. Genet. 32, 426-431 (2002).
120. Kassem, S. A., Ariel, I., Thornton, P. S., Hussain, K., Smith, V., Lindley, K. J. et al. p57(KIP2) expression in normal islet cells and in hyperinsulinism of infancy. Diabetes 50, 2763-2769 (2001).
121. Thakur, N., Tiwari, V. K., Thomassin, H., Pandey, R. R., Kanduri, M., Göndör, A. et al. An antisense RNA regulates the bidirectional silencing property of the Kcnq1 imprinting control region. Mol. Cell Biol. 24, 7855-7862 (2004).
122. Monk, D., Arnaud, P., Apostolidou, S., Hills, F. A., Kelsey, G., Stanier, P. et al. Limited evolutionary conservation of imprinting in the human placenta. Proc. Natl Acad. Sci. USA 103, 6623-6628 (2006).
123. Voight, B. F., Scott, L. J., Steinthorsdottir, V., Morris, A. P., Dina, C, Welch, R. P. et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet. 42, 579-589 (2010).
124. Unoki, H., Takahashi, A., Kawaguchi, T., Hara, K., Horikoshi, M., Andersen, G. et al. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat. Genet. 40, 1098-1102 (2008).
125. Holmkvist, J., Banasik, K., Andersen, G., Unoki, H., Jensen, T. S., Pisinger, C. et al. The type 2 diabetes associated minor allele of rs2237895 KCNQ1 associates with reduced insulin release following an oral glucose load. PLoS One 4, e5872 (2009).
126. Been, L. F., Ralhan, S., Wander, G. S., Mehra, N. K., Singh, J., Mulvihill, J. J. et al. Variants in KCNQ1 increase type II diabetes susceptibility in South Asians: a study of 3310 subjects from India and the US. BMC Med. Genet. 12, 18 (2011).
127. Wallace, C, Smyth, D. J., Maisuria-Armer, M., Walker, N. M., Todd, J. A. & Clayton, D. G. The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes. Nat. Genet. 42, 68-71 (2010).
128. Cebola, I. & Pasquali, L. Non-coding genome functions in diabetes. J. Mol. Endocrinol. 56, R1-R20 (2016).
129. Jensen, C. H., Krogh, T. N., Højrup, P., Clausen, P. P., Skjødt, K., Larsson, L. I. etal. Protein structure of fetal antigen 1 (FA1). A novel circulating human epidermal-growth-factor-like protein expressed in neuroendocrine tumors and its relation to the gene products of dlk and pG2. Eur. J. Biochem. 225, 83-92 (1994).
130. Laborda, J. The role of the epidermal growth factor-like protein dlk in cell differentiation. Histol. Histopathol. 15, 119-129 (2000).
131. Sakajiri, S., O'kelly, J., Yin, D., Miller, C. W., Hofmann, W. K., Oshimi, K. et al. Dlk1 in normal and abnormal hematopoiesis. Leukemia 19, 1404-1410 (2005).
132. Raghunandan, R., Ruiz-Hidalgo, M., Jia, Y., Ettinger, R., Rudikoff, E., Riggins, P. et al. Dlk1 influences differentiation and function of B lymphocytes. Stem Cells Dev. 17, 495-507 (2008).
133. Abdallah, B. M., Boissy, P., Tan, Q., Dahlgaard, J., Traustadottir, G. A., Kupisiewicz, K. et al. dlk1/FA1 regulates the function of human bone marrow mesenchymal stem cells by modulating gene expression of pro-inflammatory cytokines and immune response-related factors. J. Biol. Chem. 282, 7339-7351 (2007).
134. Mirza, A. H., Kaur, S., Brorsson, C. A. & Pociot, F. Effects of GWAS-associated genetic variants on lncRNAs within IBD and T1D candidate loci. PLoS One 9, e105723 (2014).
135. Cooper, J. D., Smyth, D. J., Smiles, A. M., Plagnol, V., Walker, N. M., Allen, J. E. et al. Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. Nat. Genet. 40, 1399-1401 (2008).
136. Grant, S. F., Qu, H. Q., Bradfield, J. P., Marchand, L., Kim, C. E., Glessner, J. T. et al. Follow-up analysis of genome-wide association data identifies novel loci for type 1 diabetes. Diabetes 58, 290-295 (2009).
137. Flicek, P., Amode, M. R., Barrell, D., Beal, K., Billis, K., Brent, S. et al. Ensembl 2014. Nucleic Acids Res. 42, D749-D755 (2014).
138. Roychoudhuri, R., Hirahara, K., Mousavi, K., Clever, D., Klebanoff, C. A., Bonelli, M. et al. BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis. Nature 498, 506-510 (2013).
139. Marroquí, L., Santin, I., Dos Santos,, R. S., Marselli, L., Marchetti, P. & Eizirik, D. L. BACH2, a candidate risk gene for type 1 diabetes, regulates apoptosis in pancreatic p-cells via JNK1 modulation and crosstalk with the candidate gene PTPN2. Diabetes 63, 2516-2527 (2014).
140. Gorlova, O. Y., Amos, C. I., Wang, N. W., Shete, S., Turner, S. T. & Boerwinkle, E. Genetic linkage and imprinting effects on body mass index in children and young adults. Eur. J. Hum. Genet. 11, 425-432 (2003).
141. Liu, J., Litman, D., Rosenberg, M. J., Yu, S., Biesecker, L. G. & Weinstein, L. S. A GNAS1 imprinting defect in pseudohypoparathyroidism type IB. J. Clin. Invest. 106, 1167-1174 (2000).
142. Campión, J., Milagro, F. & Martínez, J. A. Epigenetics and obesity. Prog. Mol. Biol. Transl. Sci. 94, 291-347 (2010).
143. Lavebratt, C, Almgren, M. & Ekström, T. J. Epigenetic regulation in obesity. Int. J. Obes. (Lond.) 36, 757-765(2012).
144. Lillycrop, K. A. & Burdge, G. C. Epigenetic changes in early life and future risk of obesity. Int. J. Obes. (Lond) 35, 72-83 (2011).
145. Pinnick, K. E. & Karpe, F. DNA methylation of genes in adipose tissue. Proc. Nutr. Soc. 70, 57-63 (2011).
146. Hernández-Valero, M. A., Rother, J., Gorlov, I., Frazier, M. & Gorlova, O. Interplay between polymorphisms and methylation in the H19/IGF2 gene region may contribute to obesity in Mexican-American children. J. Dev. Orig. Health Dis. 4, 499-506 (2013).
147. Perkins, E., Murphy, S. K., Murtha, A. P., Schildkraut, J., Jirtle, R. L., Demark-Wahnefried, W. et al. Insulin-like growth factor 2/H19 methylation at birth and risk of overweight and obesity in children. J. Pediatr. 161, 31-39 (2012).
148. Speliotes, E. K., Willer, C. J., Berndt, S. I., Monda, K. L., Thorleifsson, G., Jackson, A. U. et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat. Genet. 42, 937-948 (2010).
149. Kitamoto, A., Kitamoto, T., Mizusawa, S., Teranishi, H., So, R., Matsuo, T. et al. NUDT3 rs206936 is associated with body mass index in obese Japanese women. Endocr. J. 60, 991-1000 (2013).
150. Hong, K. W. & Oh, B. Recapitulation of genome-wide association studies on body mass index in the Korean population. Int. J. Obes. (Lond.) 36, 1127-1130 (2012).